Response to: Medications associated with fracture risk in patients with rheumatoid arthritis' by Chen et al

Gulsen Ozen, Kaleb Michaud

Research output: Contribution to journalLetter

Original languageEnglish (US)
JournalAnnals of the rheumatic diseases
DOIs
StateAccepted/In press - Jan 1 2019

Fingerprint

Osteoporosis
Rheumatoid Arthritis

Keywords

  • disease activity
  • osteoporosis
  • rheumatoid arthritis
  • treatment

ASJC Scopus subject areas

  • Immunology and Allergy
  • Rheumatology
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

@article{5ae1ded3e76f4fd7a992f4e6441bd6ea,
title = "Response to: Medications associated with fracture risk in patients with rheumatoid arthritis' by Chen et al",
keywords = "disease activity, osteoporosis, rheumatoid arthritis, treatment",
author = "Gulsen Ozen and Kaleb Michaud",
year = "2019",
month = "1",
day = "1",
doi = "10.1136/annrheumdis-2019-216293",
language = "English (US)",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",

}

TY - JOUR

T1 - Response to

T2 - Medications associated with fracture risk in patients with rheumatoid arthritis' by Chen et al

AU - Ozen, Gulsen

AU - Michaud, Kaleb

PY - 2019/1/1

Y1 - 2019/1/1

KW - disease activity

KW - osteoporosis

KW - rheumatoid arthritis

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85073615981&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073615981&partnerID=8YFLogxK

U2 - 10.1136/annrheumdis-2019-216293

DO - 10.1136/annrheumdis-2019-216293

M3 - Letter

C2 - 31601629

AN - SCOPUS:85073615981

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

ER -